Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
Crossref DOI link: https://doi.org/10.1007/s40265-016-0588-x
Published Online: 2016-05-26
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Festino, Lucia
Botti, Gerardo
Lorigan, Paul
Masucci, Giuseppe V.
Hipp, Jason D.
Horak, Christine E.
Melero, Ignacio
Ascierto, Paolo A.
Text and Data Mining valid from 2016-05-26